Screening biomarkers for autism spectrum disorder using plasma proteomics combined with machine learning methods.

Journal: Clinica chimica acta; international journal of clinical chemistry
PMID: 39481511

Abstract

BACKGROUND AND AIMS: Autism spectrum disorder (ASD) is a common neurodevelopmental disorder in children. Early intervention is effective. Investigation of novel blood biomarkers of ASD facilitates early detection and intervention.

Authors

  • Xiaoxiao Tang
    College of Life Science and Oceanography, Shenzhen University, Shenzhen 518071, PR China.
  • Xiaoqian Ran
    College of Life Science and Oceanography, Shenzhen University, Shenzhen 518060, China.
  • Zhiyuan Liang
    College of Life Science and Oceanography, Shenzhen University, Shenzhen 518060, China.
  • Hongbin Zhuang
    College of Life Science and Oceanography, Shenzhen University, Shenzhen 518060, China.
  • Xi Yan
    College of Life Science and Oceanography, Shenzhen University, Shenzhen 518060, China.
  • Chengyun Feng
    Maternal and Child Health Hospital of Baoan, Shenzhen 518100, PR China.
  • Ayesha Qureshi
    College of Life Science and Oceanography, Shenzhen University, Shenzhen 518071, PR China.
  • Yan Gao
    Department of Rehabilitation Medicine, The First Affiliated Hospital of Shenzhen University, The Second People's Hospital of Shenzhen, Shenzhen, Guangdong, China.
  • Liming Shen
    College of Life Science and Oceanography, Shenzhen University, Shenzhen 518060, China.

Keywords

External Resources

Popular Topics
Recent Journals